NovaBridge Biosciences NBP
NASDAQ NBP
$1.80 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Amortizatization of Intangibles (2019 - 2025)

NovaBridge Biosciences (NBP) posted quarterly Amortizatization of Intangibles of $201000.0 for Q4 2025, up 5.24% year-over-year from $191000.0 in Q4 2024, and up 1.01% quarter-over-quarter from $199000.0 in Q3 2025.

Analysis

NovaBridge Biosciences (NBP) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Amortizatization of Intangibles for 2 consecutive years, with $201000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Amortizatization of Intangibles rose 5.24% year-over-year to $201000.0; the TTM figure through Dec 2025 stood at $767000.0 (changed N/A YoY), while the FY2025 annual figure was $788000.0, up 9.9% from the prior year.
  • Amortizatization of Intangibles grew to $201000.0 in Q4 2025 per NBP's latest filing, from $199000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $201000.0 in Q4 2025 and bottomed at $176000.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 NovaBridge Biosciences 197.68 Mn 197.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 201,000.00
Sep 30, 2025 199,000.00
Dec 31, 2024 191,000.00
Sep 30, 2024 176,000.00
Dec 31, 2020 -811,655.04
Sep 30, 2020 414,943.75
Dec 31, 2019 195,227.94